Item 5.07 - Submission of Matters to a Vote of Security Holders.

Abbott held its Annual Meeting of Shareholders on April 29, 2022. The following is a summary of the matters voted on at that meeting.

(1) The shareholders elected Abbott's entire Board of Directors. The persons


     elected to Abbott's Board of Directors and the number of shares cast for, the
     number of shares withheld, and the number of broker non-votes, with respect
     to each of these persons, were as follows:




Name                        Votes For         Votes Withheld       Broker Non-Votes
Robert J. Alpern, M.D.     1,300,318,741           50,116,071            186,229,036
Sally E. Blount, Ph.D.     1,322,633,909           27,800,903            186,229,036
Robert B. Ford             1,265,246,918           85,187,894            186,229,036
Paola Gonzalez             1,344,735,483            5,699,329            186,229,036
Michelle A. Kumbier        1,328,758,586           21,676,226            186,229,036
Darren W. McDew            1,333,987,306           16,447,506            186,229,036
Nancy McKinstry            1,037,568,700          312,866,112            186,229,036
William A. Osborn          1,243,331,162          107,103,650            186,229,036
Michael F. Roman           1,321,772,019           28,662,793            186,229,036
Daniel J. Starks           1,343,614,722            6,820,090            186,229,036
John G. Stratton           1,247,765,004          102,669,808            186,229,036
Glenn F. Tilton            1,288,825,816           61,608,996            186,229,036

(2) The shareholders ratified the appointment of Ernst & Young LLP as Abbott's


     auditors. The number of shares cast in favor of the ratification of Ernst &
     Young LLP, the number against, the number abstaining, and the number of
     broker non-votes were as follows:




     For         Against     Abstain    Broker Non-Votes
1,523,487,443   9,931,288   3,245,117          0

(3) The shareholders approved the compensation of Abbott's named executive


     officers listed in the proxy statement for the Annual Meeting, with 91.27
     percent of the votes cast voting "For" the proposal. The shareholder vote is
     advisory and non-binding. The number of shares cast in favor of approval, the
     number against, the number abstaining, and the number of broker non-votes
     were as follows:




     For          Against      Abstain    Broker Non-Votes
1,232,623,436   110,410,371   7,401,005     186,229,036

(4) The shareholders rejected a shareholder proposal to lower the ownership


     threshold for calling special meetings of shareholders, with 47.15 percent of
     the votes cast voting "For" the proposal. The number of shares cast in favor
     of the shareholder proposal, the number against, the number abstaining, and
     the number of broker non-votes were as follows:




    For         Against      Abstain    Broker Non-Votes
636,741,987   707,817,833   5,874,992     186,229,036

(5) The shareholders rejected a shareholder proposal requesting that Abbott's


     Board of Directors adopt a policy that the Board Chairman be an independent
     director, with 27.75 percent of the votes cast voting "For" the proposal. The
     number of shares cast in favor of the shareholder proposal, the number
     against, the number abstaining, and the number of broker non-votes were as
     follows:




    For         Against      Abstain    Broker Non-Votes
374,824,445   971,036,526   4,573,841     186,229,036

(6) The shareholders rejected a shareholder proposal that Abbott's Board of


     Directors adopt a policy on Rule 10b5-1 plans with certain restrictions and
     disclosure requirements, with 48.76 percent of the votes cast voting "For"
     the proposal. The number of shares cast in favor of the shareholder proposal,
     the number against, the number abstaining, and the number of broker non-votes
     were as follows:




    For         Against      Abstain    Broker Non-Votes
658,539,820   684,198,068   7,696,924     186,229,036

(7) The shareholders rejected a shareholder proposal that Abbott's Board of


     Directors prepare a report, to be updated annually, disclosing Abbott's
     lobbying policies, procedures, and expenditures, with 34.52 percent of the
     votes cast voting "For" the proposal. The number of shares cast in favor of
     the shareholder proposal, the number against, the number abstaining, and the
     number of broker non-votes were as follows:






    For         Against      Abstain    Broker Non-Votes
466,227,363   877,646,614   6,560,835     186,229,036

(8) The shareholders rejected a shareholder proposal that Abbott's Board of


     Directors prepare a report on the public health costs and financial market
     impacts of Abbott's standards and programs regarding antimicrobial
     resistance, with 11.51 percent of the votes cast voting "For" the proposal.
     The number of shares cast in favor of the shareholder proposal, the number
     against, the number abstaining, and the number of broker non-votes were as
     follows:

For Against Abstain Broker Non-Votes 155,376,554 1,187,364,353 7,693,905 186,229,036

© Edgar Online, source Glimpses